Overview
NGEN market data
Price History
NGEN price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for NGEN. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jul 14, 2026, 12:19 PM
HC Wainwright & Co. Maintains Buy on NervGen Pharma, Lowers Price Target to $15Benzinga · Jul 14, 2026, 10:19 AM
Leerink Partners Initiates Coverage On NervGen Pharma with Outperform Rating, Announces Price Target of $10Benzinga · Jul 13, 2026, 5:59 PM
NervGen Pharma Increases Mixed Shelf Offering From $150M To $250MBenzinga · May 26, 2026, 1:31 PM
Why Is NervGen Pharma Stock Gaining Tuesday?Benzinga · May 26, 2026, 12:33 PM
NervGen Pharma Announces Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery With NVG-291 In The Phase 1B/2a CONNECT SCI Study; Notes 100% Of Subjects Were Classified As Responders Against 10% For PlaceboBenzinga · May 26, 2026, 11:18 AM
Crude Oil Edges Higher; US Consumer Sentiment Falls In MayBenzinga · May 22, 2026, 5:05 PM
Dow Jumps 250 Points; BJ's Wholesale Shares Fall After Q1 ResultsBenzinga · May 22, 2026, 1:50 PM
Why Estee Lauder Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving PremarketBenzinga · May 22, 2026, 1:05 PM
NervGen Pharma Announces Commencement Of Public Offering Of Common SharesBenzinga · May 21, 2026, 8:10 PM